Open Letter to Ambassador John Nkengasong as PEPFAR Global Coordinator

Afrocab shared a letter from about 200 advocates that shares our concern regarding the slow pace at which the important drug Cabotegravir – Long-Acting (CAB-LA) is made accessible to all who need it.
We welcome Dr Nkengasong’s leadership in engaging key stakeholders, including the originator manufacturer ViiV Healthcare, policy-makers, such as WHO and national governments, and communities most at risk of HIV infection, to remove all access barriers.
The letter can be found here

Published: May 26, 2022